Doxycycline injection is used to treat or prevent bacterial infections, including pneumonia and other respiratory tract infections. It is also used to treat certain skin, genital, intestine, and urinary system infections. Doxycycline injection may be used to treat or prevent anthrax (a serious infection that may be spread on purpose as part of a bioterror attack) in people who may have been exposed to anthrax in the air. Doxycycline injection is in a class of medications called tetracycline antibiotics. It works by killing bacteria that cause infections.

The global Doxycycline Injection market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Doxycycline Injection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Doxycycline Injection market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Doxycycline Injection in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Doxycycline Injection manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Fresenius Kabi
Mylan
West-Ward Pharmaceuticals
Zydus Pharmaceuticals
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
100 mg per vial
Type II

Segment by Application
Hospital
Drug store